John M. Evans is CEO at Beam Therapeutics Inc. (BEAM). They have made 11 open-market trades across 1 company since 2020, most recently 2026-10-16.
CIK 0001786304
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BEAM | 1,047,205 | $24.6M |
Shares reported on the most recent Form 4, priced at the 2026-10-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BEAM | SELL · 10b5-1 | 2026-10-15 | 2026-10-16 | $23.77 | $1.2M | — | — | — |
| BEAM | SELL · 10b5-1 | 2026-06-29 | 2026-07-01 | $34.90 | $1.7M | -9.3% | -25.1% | -28.0% |
| BEAM | SELL · 10b5-1 | 2026-04-01 | 2026-04-06 | $24.58 | $739K | +25.2% | +33.4% | +45.7% |
| BEAM | SELL · 10b5-1 | 2026-03-30 | 2026-04-01 | $22.57 | $1.1M | +28.8% | +30.7% | +45.8% |
| BEAM | SELL | 2026-01-29 | 2026-02-02 | $28.87 | $1.4M | -2.8% | -1.0% | +8.4% |
| BEAM | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $24.57 | $1.2M | +4.5% | -6.8% | +4.3% |
| BEAM | SELL · 10b5-1 | 2025-04-01 | 2025-04-03 | $18.35 | $1.1M | +9.2% | +25.2% | +25.6% |
| BEAM | SELL · 10b5-1 | 2025-01-30 | 2025-02-03 | $26.75 | $803K | +11.2% | +1.5% | -22.9% |
| BEAM | SELL · 10b5-1 | 2024-09-30 | 2024-10-02 | $24.60 | $1.5M | +14.8% | -1.0% | +7.0% |
| BEAM | SELL · 10b5-1 | 2024-06-27 | 2024-06-28 | $24.50 | $1.5M | +10.4% | +36.6% | +7.1% |
| BEAM | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $32.13 | $1.2M | -13.6% | -22.3% | -24.1% |
| BEAM | SELL · 10b5-1 | 2024-03-28 | 2024-04-01 | $33.86 | $2.0M | -11.0% | -29.1% | -24.8% |
| BEAM | SELL · 10b5-1 | 2024-01-31 | 2024-02-02 | $25.33 | $1.5M | +24.0% | +51.6% | -9.9% |
| BEAM | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $29.63 | $691K | +6.0% | +14.6% | +8.5% |
| BEAM | SELL | 2022-10-31 | 2022-11-02 | $46.33 | $4.6M | +16.7% | +9.9% | +2.0% |
| BEAM | SELL | 2022-07-28 | 2022-07-29 | $65.75 | $6.6M | +14.5% | -4.1% | -19.3% |
| BEAM | SELL | 2022-04-28 | 2022-05-02 | $37.97 | $3.5M | -23.1% | -16.8% | +43.9% |
| BEAM | SELL | 2022-03-31 | 2022-04-04 | $59.11 | $740K | -24.9% | -30.1% | -24.7% |
| BEAM | SELL | 2022-01-31 | 2022-02-02 | $66.87 | $6.5M | +11.1% | +5.1% | -34.3% |
| BEAM | SELL | 2021-10-06 | 2021-10-08 | $83.79 | $8.0M | +14.0% | +20.0% | -14.1% |
| BEAM | SELL | 2021-08-19 | 2021-08-20 | $99.56 | $3.8M | +6.9% | -9.2% | -14.6% |
| BEAM | SELL | 2021-07-07 | 2021-07-08 | $107.91 | $4.0M | -5.7% | +6.3% | -16.6% |
| BEAM | SELL | 2021-04-21 | 2021-04-23 | $70.49 | $3.5M | -5.1% | -3.5% | +23.6% |
| BEAM | SELL | 2020-12-30 | 2021-01-04 | $85.38 | $3.0M | +38.8% | +24.0% | +0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.